<DOC>
	<DOCNO>NCT01234792</DOCNO>
	<brief_summary>Single-dose nicotine pharmacokinetics three oral nicotine replacement product .</brief_summary>
	<brief_title>Single-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products . A Study Healthy Smokers .</brief_title>
	<detailed_description>The study single-dose , randomize , crossover study 24 subject ( subject receive treatment ) . The investigational product 6 mg , 4 mg 2 mg Nicotine medicate gum give single dos separate treatment visit . Periods without NRT , last least 36 hour , separate treatment visit . Blood pharmacokinetic analysis draw , 2.5 , 5 , 7.5 , 10 , 15 , 20 , 30 , 45 , 60 minute well 1.5 , 2 , 4 , 6 , 8 hour start product administration . Subjects also monitor capture adverse event may occur . The trial blind sense treatment label reveal subject trial personnel . Also bioanalysts , pharmacokineticists monitor unaware treatment label .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Healthy subject , smoke least 15 cigarette daily least one year precede inclusion BMI 17.5 30.0 kg/m2 total body weight least 55.0 kg . Female participant childbearing potential require use medically acceptable mean birth control . A personally sign date informed consent document , indicate subject inform pertinent aspect study . Pregnancy , lactation intend pregnancy . Treatment investigational product donation loss blood within 3 month precede first dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Smoking Cessation , Nicotine pharmacokinetics</keyword>
</DOC>